ANAVEX LIFE SCIENCES CORP. Common Stock, Value, Issued
ANAVEX LIFE SCIENCES CORP. (AVXL) had Common Stock, Value, Issued of $93.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-28.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-28
- 2026-06-30: Common Stock, Value, Issued $93.00K.
- 2026-03-31: Common Stock, Value, Issued $93.00K.
- 2025-12-31: Common Stock, Value, Issued $93.00K.
- 2025-09-30: Common Stock, Value, Issued $87.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $93.00K 10-Q · filed 2026-08-28 | |
| 2026-03-31 | $93.00K 10-Q · filed 2026-08-28 | |
| 2025-12-31 | $93.00K 10-Q · filed 2026-02-09 | |
| 2025-09-30 | $87.00K 10-K/A · filed 2026-08-28 | |
| 2025-06-30 | $85.00K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $85.00K 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $85.00K 10-Q · filed 2025-02-12 | |
| 2024-09-30 | $85.00K 10-K/A · filed 2026-08-28 | |
| 2024-06-30 | $85.00K 10-Q · filed 2024-08-06 | |
| 2024-03-31 | $84.00K 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $82.00K 10-Q · filed 2024-02-07 | |
| 2023-09-30 | $82.00K 10-K · filed 2024-12-23 | |
| 2023-06-30 | $81.39K 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $80.24K 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $78.03K 10-Q · filed 2023-02-07 | |
| 2022-09-30 | $78.00K 10-K · filed 2023-11-27 | $77.94K 10-K · filed 2022-11-28 |
| 2022-06-30 | $77.94K 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $77.16K 10-Q · filed 2022-05-10 | |
| 2021-12-31 | $76.16K 10-Q · filed 2022-02-09 | |
| 2021-09-30 | $75.92K 10-K · filed 2022-11-28 | |
| 2021-03-31 | $70.03K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $66.96K 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $62.05K 10-K · filed 2021-11-24 | |
| 2020-06-30 | $60.08K 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $58.67K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $57.08K 10-Q · filed 2020-02-06 | |
| 2019-09-30 | $52.65K 10-K · filed 2020-12-28 | |
| 2019-06-30 | $51.51K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $48.17K 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $46.89K 10-Q · filed 2019-02-07 | |
| 2018-09-30 | $45.94K 10-K · filed 2019-12-16 | |
| 2018-06-30 | $45.31K 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $44.58K 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $44.42K 10-Q · filed 2018-02-07 | |
| 2017-09-30 | $43.33K 10-K · filed 2019-01-25 | |
| 2017-06-30 | $42.17K 10-Q · filed 2017-08-07 | |
| 2017-03-31 | $41.38K 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $40.67K 10-Q · filed 2017-02-07 | |
| 2016-09-30 | $36.17K 10-K · filed 2017-12-11 | |
| 2016-06-30 | $35.71K 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $35.70K 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $34.66K 10-Q · filed 2016-02-08 | |
| 2015-09-30 | $32.04K 10-K · filed 2016-12-14 | |
| 2015-06-30 | $86.22K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $64.88K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $54.81K 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $11.80K 10-K · filed 2015-12-29 | $47.20K 10-K · filed 2014-12-29 |
| 2014-06-30 | $38.26K 10-Q · filed 2014-08-13 | |
| 2014-03-31 | $38.26K 10-Q/A · filed 2014-05-30 | |
| 2013-12-31 | $37.64K 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $37.24K 10-K · filed 2014-12-29 | |
| 2013-06-30 | $30.24K 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $30.24K 10-Q · filed 2013-05-17 | |
| 2012-12-31 | $30.24K 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $30.24K 10-K · filed 2013-12-30 | |
| 2012-06-30 | $30.17K 10-Q · filed 2012-08-17 | |
| 2011-09-30 | $26.57K 10-K · filed 2012-12-31 | |
| 2011-06-30 | $25.92K 10-Q · filed 2011-08-12 | |
| 2010-09-30 | $23.52K 10-K · filed 2011-12-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |